GlaxoSmithKline

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Public

Established: 1929-01-01

Employees: 70.2K

Market Cap: $90B

Website: http://www.gsk.com

Introduction: GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Clinical Trials

A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitis

Phase 2

Withdrawn

Conditions: Colitis, Ulcerative

Interventions: Other: Placebo
Drug: GSK1605786

First Posted Date: 2012-08-07

Last Posted Date: 2013-06-24

Lead Sponsor: GlaxoSmithKline

Registration Number: NCT01658605

Locations: 🇬🇧
GSK Investigational Site, Oxford, Oxfordshire, United Kingdom

A Study to Look at the Electrical Activity of the Heart in Subjects With Solid Tumor Cancers, Before and After Receiving the Study Treatment, GSK1120212

Phase 1

Completed

Conditions: Cancer

Interventions: Drug: GSK1120212

First Posted Date: 2012-08-07

Last Posted Date: 2017-11-13

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 60

Registration Number: NCT01658553

Locations: 🇺🇸
GSK Investigational Site, Salt Lake City, Utah, United States

Bioequivalence - Duodart Against Avodart & Omnic

Phase 1

Completed

Conditions: Prostatic Hyperplasia

Interventions: Drug: dutasteride
Drug: dutasteride/tamsulosin
Drug: tamsulosin

First Posted Date: 2012-08-06

Last Posted Date: 2017-06-20

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 35

Registration Number: NCT01657851

Locations: 🇷🇺
GSK Investigational Site, Reutov, Moscow Region, Russian Federation

Anti-caries Potential of a Sodium Monofluorophosphate and Calcium Sodium Phosphosilicate Dentifrice

Phase 2

Completed

Conditions: Caries

Interventions: Drug: Calcium sodium phosphosilicate
Drug: Placebo
Drug: Sodium monoflurophosphate

First Posted Date: 2012-08-06

Last Posted Date: 2014-10-01

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 100

Registration Number: NCT01657877

Locations: 🇺🇸
Indiana University School of Dentistry, Indianapolis, Indiana, United States

Evaluation of Efficacy of Experimental Gel to Foam Dentifrices in Dental Erosion

Not Applicable

Completed

Conditions: Dental Erosion
Acid Wear

Interventions: Drug: Sodium Fluoride
Drug: Potassium nitrate

First Posted Date: 2012-08-06

Last Posted Date: 2015-01-26

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 56

Registration Number: NCT01657903

Locations: 🇺🇸
Indiana University School of Dentistry, Indianapolis, Indiana, United States

WEUSKOP6166: Lamotrigine and Aseptic Meningitis

Completed

Conditions: Epilepsy

Interventions: Drug: Lamotrigine

First Posted Date: 2012-08-06

Last Posted Date: 2012-08-06

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 1

Registration Number: NCT01657864

Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Non-typeable Haemophilus Influenzae (NTHI) Vaccine

Phase 1

Completed

Conditions: Respiratory Disorders

Interventions: Biological: Saline placebo
Biological: GSK Biologicals' Non-Typeable H. influenzae (GSK2838500A)
Biological: GSK Biologicals' Non-Typeable H. influenzae (GSK2838501A)